Sports Medicine market is expected to reach US$ 12.32 billion by 2033 from US$ 7.27 billion in 2024, with a CAGR of 6.04% from 2025-2033. Among the factors driving the market demand are rising sports participation, increased awareness of preventive care, continuous technological advancements, an increase in sports injuries, increased funding for research and development (R&D), rising healthcare expenditures, a growing emphasis on personalized care, the introduction of telemedicine, and more. Read More: https://www.renub.com/sports-medicine-market-p.php #Sports_Medicine_Market #Sports_Medicine_Market_Trends #Sports_Medicine_Market_Size #Sports_Medicine_Market_Share

The telemedicine market is expected to grow at a substantial rate, with an estimated size of US$ 618.34 billion in 2033 from US$ 83.23 billion in 2024 at a CAGR of 24.96% during 2025-2033. This rapid growth is facilitated by the increased adoption of digital healthcare solutions, increased access to medical services, and the advancement in telecommunication technologies. Read More: https://www.renub.com/telemedicine-market-p.php #Telemedicine_Market #Telemedicine_Market_Trends #Telemedicine_Market_Size #Telemedicine_Market_Share

Anticoagulants market is expected to reach US$ 41.31 billion in 2024 to US$ 89.50 billion by 2033, with a CAGR of 8.97 % from 2025 to 2033. Sedentary lifestyles, a better healthcare system, and an increase in thrombotic disease instances are some of the major drivers propelling the market. Read More: https://www.renub.com/anticoagulation-market-p.php #Anticoagulants_Market #Anticoagulants_Market_Trends #Anticoagulants_Market_Size #Anticoagulants_Market_Share